Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model

Open access

Abstract

Purpose: Low free testosterone (T) level in men is independently associated with presence and severity of Non-Alcoholic Steatohepatitis (NASH). The histological and molecular effects of oral testosterone prodrug LPCN 1144 treatment on hepatic fibrosis and NASH features are unknown. A metabolic syndrome-induced NASH model in rabbits consuming high fat diet (HFD) has been previously used to assess treatment effects of injectable T on hepatic fibrosis and NASH features. Here we present results on LPCN 1144 in this HFD-induced, NASH preclinical model. Methods: Male rabbits were randomly assigned to five groups: regular diet (RD), HFD, HFD + 1144 vehicle (HFD + Veh), HFD + 1144 (1144), and HFD + 1144 + α-tocopherol (1144 + ALPHA). Rabbits were sacrificed after 12 weeks for liver histological, biochemical and genetic analyses. Histological scores were obtained through Giemsa (inflammation), Masson’s trichrome (steatosis and ballooning), and Picrosirius Red (fibrosis) staining. Results: Compared to RD, HFD and HFD + Veh significantly worsened NASH features and hepatic fibrosis. Considering HFD and HFD + Veh arms, histological and biomarker features were not significantly different. Both 1144 and 1144 + ALPHA arms improved mean histological scores of NASH as compared to HFD arm. Importantly, percentage of fibrosis was improved in both 1144 ( p < 0.05) and 1144 + ALPHA ( p = 0.05) treatment arms vs. HFD. Both treatment arms also reduced HFD-induced inflammation and fibrosis mRNA markers. Furthermore, 1144 treatments significantly improved HFD-induced metabolic dysfunctions. Conclusions: Histological and biomarker analyses demonstrate that LPCN 1144 improved HFD-induced hepatic fibrosis and NASH biochemical, biomolecular and histochemical features. These preclinical findings support a therapeutic potential of LPCN 1144 in the treatment of NASH and of hepatic fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40618-021-01522-7

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Representative images of dissected carcasses from each experimental group
Fig. 1 Representative images of dissected carcasses from each experimental groupCC BY · PubMed Central
Fig. 2 Giemsa staining of liver specimens. Representative images of RD (a, f), HFD (b, g), HFD + Veh (c, h), 1144 (d, i), and 1144 + ALPHA (e, j) samples at ×100 and ×200 original magnifications, respectively. Black arrows indicate foci of inflammatory mononuclear infiltrates (dark blue/purple nuclei). Scale bar = 50 µm
Fig. 2 Giemsa staining of liver specimens. Representative images of RD (a, f), HFD (b, g), HFD + Veh (c, h), 1144 (d, i), and 1144 + ALPHA (e, j) samples at ×100 and ×200 original magnifications, respectively. Black arrows indicate foci of inflammatory mononuclear infiltrates (dark blue/purple nuclei). Scale bar = 50 µmCC BY · PubMed Central
Fig. 3 Masson’s trichrome histomorphological analysis of liver sections steatosis. a–e Show representative images of RD, HFD, HFD + Veh, 1144, and 1144 + ALPHA samples, respectively. CV central vein; P portal area. Scale bar = 100 µm
Fig. 3 Masson’s trichrome histomorphological analysis of liver sections steatosis. a–e Show representative images of RD, HFD, HFD + Veh, 1144, and 1144 + ALPHA samples, respectively. CV central vein; P portal area. Scale bar = 100 µmCC BY · PubMed Central
Fig. 4 Masson’s trichrome histomorphological analysis of liver sections ballooning. a–e Show representative images of RD, HFD, HFD + Veh, 1144, and 1144 + ALPHA samples, respectively. CV central vein. Scale bar = 50 µm
Fig. 4 Masson’s trichrome histomorphological analysis of liver sections ballooning. a–e Show representative images of RD, HFD, HFD + Veh, 1144, and 1144 + ALPHA samples, respectively. CV central vein. Scale bar = 50 µmCC BY · PubMed Central
Fig. 5 Picrosirius Red analysis of collagen deposition in rabbit liver sections. Representative images of RD (a, f), HFD (b, g), HFD + Veh (c, h), 1144 (d, i), and 1144 + ALPHA (e, j) samples at ×40 and ×100 original magnifications, respectively. CV central vein, P portal area. Scale bar = 100 µm
Fig. 5 Picrosirius Red analysis of collagen deposition in rabbit liver sections. Representative images of RD (a, f), HFD (b, g), HFD + Veh (c, h), 1144 (d, i), and 1144 + ALPHA (e, j) samples at ×40 and ×100 original magnifications, respectively. CV central vein, P portal area. Scale bar = 100 µmCC BY · PubMed Central
Fig. 6 Picrosirius Red analysis of collagen deposition in rabbit liver sections. a Shows the percentage of collagen over the sampled area in RD, HFD, HFD + Veh, 1144 and 1144 + ALPHA groups (*p < 0.05, **p < 0.01, ***p < 0.001 vs. RD; °p < 0.05, $p = 0.051 vs. HFD). b Shows the percentage of collagen over the sampled area in relation to fibrosis Ishak scores (F0 = 0, F1 = 1, F2 = 2, F3 = 3, F4 = 4; *p < 0.001 vs. F1; °p < 0.001 vs. F2). c Shows the Spearman’s correlation of fibrosis Ishak scores and percentage of sampled area (r = 0.853; p = 0.000)
Fig. 6 Picrosirius Red analysis of collagen deposition in rabbit liver sections. a Shows the percentage of collagen over the sampled area in RD, HFD, HFD + Veh, 1144 and 1144 + ALPHA groups (*p < 0.05, **p < 0.01, ***p < 0.001 vs. RD; °p < 0.05, $p = 0.051 vs. HFD). b Shows the percentage of collagen over the sampled area in relation to fibrosis Ishak scores (F0 = 0, F1 = 1, F2 = 2, F3 = 3, F4 = 4; *p < 0.001 vs. F1; °p < 0.001 vs. F2). c Shows the Spearman’s correlation of fibrosis Ishak scores and percentage of sampled area (r = 0.853; p = 0.000)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 7

Metadata

Authors
Comeglio, P., Sarchielli, E., Filippi, S., Cellai, I., Guarnieri, G., Morelli, A., Rastrelli, G., Maseroli, E., Cipriani, S., Mello, T., Galli, A., Bruno, B. J., Kim, K., Vangara, K., Papangkorn, K., Chidambaram, N., Patel, M. V., Maggi, M., & Vignozzi, L.
Affiliations
  • University of Florence (IT)
  • Lipocine (United States) (US)
  • Istituto Nazionale Biostrutture e Biosistemi (IT)
Corresponding author
Vignozzi, L.
Venue
Journal of Endocrinological Investigation
Published
2021-02-13
Volume
44
Issue
10
Pages
2175-2193
ISSN
  • 0391-4097 (ISSN-L)
  • 1720-8386
OpenAlex
W3130590219
Cited by
7
References
62
Citations by year
2026: 2 · 2024: 1 · 2022: 2 · 2021: 2
FWCI
0.90
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Endocrinological Investigation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Florence Research (University of Florence) (submittedVersion, other-oa)
Funders
  • Lipocine Inc.
  • Università degli Studi di Firenze
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
nonalcoholic steatohepatitis, liver fibrosis, high-fat diet, liver health, metabolic regulation, alpha-tocopherol, liver inflammation, steatosis, metabolic syndrome, rabbit model
MeSH terms
Androgens, Animals, Disease Models, Animal, Fibrosis, Inflammation, Male, Prodrugs, Rabbits, Testosterone, Metabolic Syndrome, Diet, High-Fat, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model. https://app.cochat.ai/papers/10.1007/s40618-021-01522-7
The paper
Comeglio, P., Sarchielli, E., Filippi, S., Cellai, I., Guarnieri, G., Morelli, A., Rastrelli, G., Maseroli, E., Cipriani, S., Mello, T., Galli, A., Bruno, B. J., Kim, K., Vangara, K., Papangkorn, K., Chidambaram, N., Patel, M. V., Maggi, M., & Vignozzi, L. (2021). Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-021-01522-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.